American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
34.75
-0.18 (-0.52%)
At close: May 12, 2025, 4:00 PM
33.85
-0.90 (-2.59%)
After-hours: May 12, 2025, 7:51 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for American Healthcare REIT stock ranges from a low of $29 to a high of $37. The average price target of $33.86 forecasts a -2.56% decrease in the stock price over the next year.
Price Target: $33.86 (-2.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
Buy | 5 | 5 | 5 | 4 | 4 | 4 |
Hold | 1 | 1 | 1 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 6 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +6.47% | Apr 28, 2025 |
Keybanc | Keybanc | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | -2.16% | Mar 31, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +6.47% | Mar 25, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $34 | Buy | Reiterates | $34 | -2.16% | Mar 19, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +0.72% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
2.23B
from 2.06B
Increased by 8.10%
Revenue Next Year
2.37B
from 2.23B
Increased by 6.36%
EPS This Year
0.37
from -0.29
EPS Next Year
0.56
from 0.37
Increased by 52.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.4B | 2.6B | 2.9B |
Avg | 2.2B | 2.4B | 2.7B |
Low | 2.1B | 2.1B | 2.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 16.8% | 18.6% | 21.6% |
Avg | 8.1% | 6.4% | 14.3% |
Low | 0.2% | -4.3% | 8.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.44 | 0.65 | 0.83 |
Avg | 0.37 | 0.56 | 0.80 |
Low | 0.26 | 0.47 | 0.77 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 76.6% | 48.0% |
Avg | - | 52.1% | 42.3% |
Low | - | 27.6% | 38.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.